GPR137 is a promising novel bio-marker for the prognosis of bladder cancer patients
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference27 articles.
1. The global burden of urinary bladder cancer;Parkin;Scand J Urol Nephrol Suppl,2008
2. Bladder cancer;Kaufman;Lancet,2009
3. Urinary markers in bladder cancer;Vrooman;Eur Urol,2008
4. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer;Wang;J Surg Oncol,2015
5. Novel human G-protein-coupled receptors;Vanti;Biochem Biophys Res Commun,2003
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic DNA mutation and mRNA expression analysis of perineural invasion in oral squamous cell carcinoma;Scientific Reports;2024-01-29
2. GPR137 inactivates Hippo signaling to promote gastric cancer cell malignancy;Biology Direct;2024-01-02
3. Prognostic Risk Prediction of Bladder Cancer Patients Regarding the Tumor-Node-Metastasis Staging System and Tumor Infiltration;2023-06-29
4. ALKBH1 contributes to renal cell carcinoma progression by reducing N6‐methyladenine of GPR137;European Journal of Clinical Investigation;2023-03-23
5. Profiling of G-Protein Coupled Receptors in Adipose Tissue and Differentiating Adipocytes Offers a Translational Resource for Obesity/Metabolic Research;Cells;2023-01-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3